A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease

NCT0072404828 sitesClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease